“Paxlovid’s usefulness is questionable and could lead to resistance. I would follow the meds and supplements suggested by FLCC”
Their guide says:
In a follow up post-marketing study, Paxlovid proved to be ineffective in patients less than 65 years of age and in those who were vaccinated.
This is wrong. The study reports the following:
Among the 66,394 eligible patients 40 to 64 years of age, 1,435 were treated with nirmatrelvir. Hospitalizations due to Covid-19 occurred in 9 treated and 334 untreated patients: adjusted HR 0.78 (95% CI, 0.40 to 1.53). Death due to Covid-19 occurred in 1 treated and 13 untreated patients; adjusted HR: 1.64 (95% CI, 0.40 to 12.95).
As the abstract says, the study did not have the statistical power to show a benefit for preventing severe outcomes in younger adults. It did not “prove [Paxlovid] to be ineffective”! This is very bad, the guide is clearly not a reliable source of information about covid treatments, and I recommend against following the advice of anything else on that website.
Their guide says:
This is wrong. The study reports the following:
As the abstract says, the study did not have the statistical power to show a benefit for preventing severe outcomes in younger adults. It did not “prove [Paxlovid] to be ineffective”! This is very bad, the guide is clearly not a reliable source of information about covid treatments, and I recommend against following the advice of anything else on that website.